Rana Anjum, based in Boston, MA, US, is currently a Director, Immuno-Oncology Clinical Development at GSK, bringing experience from previous roles at AstraZeneca. Rana Anjum holds a HMX Pro course - Immuno-oncology @ Harvard Medical School. With a robust skill set that includes Cell Culture, Protein Expression, In Vivo, Protein Chemistry, Drug Discovery and more, Rana Anjum contributes valuable insights to the industry. Rana Anjum has 2 emails on RocketReach.